Acevedo GS, Espino SS, Gallardo GJM, Velásquez TB, Camargo ML, Guzmán HME

Idioma: Español
Referencias bibliográficas: 26
Paginas: 230-245
Archivo PDF: 429.82 Kb.

RESUMEN

La placenta humana, aún un enigma en muchos aspectos, ha sido motivo de exhaustivo estudio en las últimas décadas, si bien, aún escapan a nuestra comprensión muchos aspectos de la inmunología y genética de este complejo órgano, con los conocimientos actuales podemos crear un concepto práctico y global de los aspectos más importantes que nos permitan comprender y vincular en su exacta latitud las patologías que afectan el crecimiento del feto y su interacción con el matroambiente.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Moffett A, Loke YW. The immunological paradox of pregnancy: A reappraisal. Placenta 2004; 25: 1-8.

2. Sherer DM, Abulafia O. Angiogénesis during implantation, and placental and early embryonic development. Placenta 2001; 22: 1-13.

3. Demir R, Kayisli UA, Seval Y, Celic-Ozeci C, et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta 2004; 25: 560-72.

4. Arroyo J, Torry RJ, Torry DS. Deferential regulation of placenta growth factor (PlGF) –mediated signal transduction in human primary term trophoblast and endothelial cells. Placenta 2004; 25: 379-86.

5. Reganault TRH, Orbus RJ, de Vrijer B, Davidsen ML, et al. Placental expression of VEGF and their receptors in a model of placental insuffiency – intrauterine growth restriction (Pl-IUGR). Placenta 2002; 23: 132-44.

6. Kaufmann P, Scheffen I. Placental development. En: Polin RA, Fox WW (eds.). Fetal and neonatal physiology. Philadelphia: WB Saunders Company; 1998, p. 59-115.

7. Kelly B, Stone S, Poston L. Cardiovascular adaptation to pregnancy: The role of altered vascular structure. Fet Mat Med Rev 1999; 11: 105-16.

8. Hauguel de Mouzon S, Shafrir E. Carbohidrate and fat metabolism and related hormonal regulation in normal and diabetic placenta. Placenta 2001; 22: 619-27.

9. Haggarty P. Placental regulation of fatty acid delivery and its effect on fetal growth-A review. Placenta 2002; 23: S28-S38.

10. Battaglia FC, Regnault RH. Placental transport and metabolism of amino acids. Placenta 2001; 22: 146-61.

11. Cariappa R, Heath-Monnig E, Smith CH. Isoforms of amino acid transporters in placental syncytiotrophoblast: plasma membrane localization and potential role in maternal/fetal transport. Placenta 2004; 24: 713-26.

12. Jannson T, Ylben K, Wennergren M, Powell TL. Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction. Placenta 2002; 23: 392-9.

13. Manning FA. Fetal Medicine. Pinciples and practice. 1st. Ed. Ed. Masson; 1995.

14. Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996; 33: 529-33.

15. Lin CC, Santolaya-Forjas J. Current concepts of fetal growth restriction: Part I. Causes, classification, and pathophysiology. Obstet Gynecol 1998; 92: 1044-55.

16. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 2004; 25: 103-13.

17. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during pregnancy. Placenta 2004; 25: 114-26.

18. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004; 25: 127-39.

19. Villanueva LA, Pedernera E, García Lara E. Bases fisiopatológicas de la preeclampsia: una hipótesis. Ginecol Obstet Méx 1999; 67: 246-52.

20. Goldman-Wohl D, Greenfield C, Haimov-Kochman R, Ariel I, et al. Eph and Ephrin expression in normal placental development and preeclampsia. Placenta 2004; 25: 623-30.

21. Thapa L, He CM, Chen HP. Study on the expression of angiotensin II receptor subtype 1 in the placenta of pregnancy-induced hypertension. Placenta 2004; 25: 637-41.

22. Huppertz B. Kaufmann P, Kingdom J. Trophoblast turnover in health and disease. Fet Mat Med Rev 2002; 13: 103-8.

23. Rajakumar A, Brandon HM, Daftary A, Ness R, Conrad KP. Evidence for the functional activity of hypoxia inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004; 25: 763-9.

24. Fowden AL. The insulin-like growth factor and feto-placental growth. Placenta 2003; 24: 803-12.

25. Hauguel de Mouzon S, Shafrir E. Carbohydrate and fat mebolism and related hormonal regulation in normal and diabetic placenta. Placenta 2001; 22: 619-27.

26. Couglan MT, Vervaart PP, Parmezel M, Georgiou HM, Rice GE. Altered placental oxidative stress status in fetational diabetes mellitus. Placenta 2004; 25: 78-94.